Trinity Biotech (TRIB) Asset Writedowns and Impairment (2022 - 2024)
Trinity Biotech (TRIB) posted Asset Writedowns and Impairment of $290000.0 for Q4 2023, up 113.98% sequentially from -$2.1 million in Q4 2022, and up 113.98% YoY from $135529.3 in Q4 2022.
Trinity Biotech (TRIB) Asset Writedowns and Impairment (2022 - 2024) Analysis & Trends
Trinity Biotech has reported Asset Writedowns and Impairment for 2 years, with the latest figure at $290000.0 in Q4 2023.
- Quarterly Asset Writedowns and Impairment rose 113.98% year-over-year to $290000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $503000.0 (changed N/A YoY) and the FY2025 annual result came in at $2.2 million, up 54.62% from the prior year.
- Asset Writedowns and Impairment rose to $290000.0 in Q4 2023 per TRIB's latest filing, from -$2.1 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $2.3 million in Q3 2022 and troughed at -$2.1 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.53 Mn | 1.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 446.00 |
| Jun 30, 2024 | 446.00 |
| Dec 31, 2023 | 290,000.00 |
| Dec 31, 2023 | 290,000.00 |
| Dec 31, 2022 | -2.08 Mn |
| Dec 31, 2022 | -2.08 Mn |
| Sep 30, 2022 | 2.29 Mn |
| Sep 30, 2022 | 2.29 Mn |